Hybridopa Shows Motor, Nonmotor Gains in Phase 2a Parkinson Disease Trial

May 21, 2026

More like this

Remepy’s app-drug combo heads for Phase III on mid-stage Parkinson’s win

Clinical Trials Arena

Remepy's hybrid Parkinson's therapy poised for phase 3

Pharmaphorum

Remepy posts strong Phase IIa results for Hybridopa

The Pharma Letter